Shake Shack's stock dropped more than 10% after the company lowered its full-year 2026 revenue, margin, and EBITDA guidance due to macroeconomic uncertainty, competitive pressures, rising beef costs, and weak sales from weather impacts. The company reduced its Q2 revenue and same-store sales growth forecasts, along with profit margin and restaurant opening targets. This guidance cut came just weeks after the CEO had reaffirmed 2026 targets, causing investor concerns and prompting a securities investigation into possible undisclosed risks. Shareholders who suffered losses are being encouraged to seek legal advice.
DBV Technologies has begun screening the first participant in its phase 2 THRIVE clinical trial to test the VIASKIN Peanut patch on infants aged 6 to 12 months with peanut allergies. The study aims to evaluate the patch's safety and effectiveness in ...
Robbins LLP is investigating Beta Bionics, Inc.'s officers and directors for potential violations of securities laws and breaches of fiduciary duties following the company's announcement of weaker-than-expected patient growth. Beta Bionics reported a...
Robbins LLP is investigating whether officers and directors of Simulation Plus, Inc. violated securities laws and breached fiduciary duties following significant stock price drops in 2025. The company faced a 24% stock decline after lowering revenue ...
WuXi Biologics has been named to the CDP Supplier Engagement Assessment A List for the second consecutive year, recognizing its leadership in climate-related supplier engagement and strong sustainability performance. The company also earned spots on ...
Strategy Inc. sold 32 BTC for $2.5 million to fund preferred stock dividends, spotlighting a growing challenge for bitcoin treasury companies: managing liquidity without selling core bitcoin holdings. This small sale, from a large BTC reserve, raises...
